Dark Forest Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-45,319
| Closed | -$832K | – | 1197 |
|
|
2024
Q4 | $832K | Sell |
45,319
-29,225
| -39% | -$536K | 0.12% | 221 |
|
|
2024
Q3 | $1.15M | Buy |
74,544
+41,634
| +127% | +$640K | 0.15% | 142 |
|
|
2024
Q2 | $535K | Buy |
+32,910
| New | +$535K | 0.1% | 256 |
|
|
2023
Q4 | – | Sell |
-95,735
| Closed | -$2M | – | 435 |
|
|
2023
Q3 | $2M | Buy |
95,735
+30,769
| +47% | +$641K | 0.15% | 128 |
|
|
2023
Q2 | $1.56M | Buy |
64,966
+56,388
| +657% | +$1.35M | 0.14% | 135 |
|
|
2023
Q1 | $161K | Buy |
+8,578
| New | +$161K | 0.04% | 485 |
|
|
2022
Q1 | – | Sell |
-232
| Closed | -$5K | – | 1213 |
|
|
2021
Q4 | $5K | Sell |
232
-415
| -64% | -$8.94K | ﹤0.01% | 1132 |
|
|
2021
Q3 | $11K | Buy |
+647
| New | +$11K | ﹤0.01% | 965 |
|